SRI offers a wide range of services for the discovery stage of drug development programs.

Our services include—but are not limited to—

• ADMET & in vitro metabolism
• Cell-based assays
• Drug metabolism and PK
• Electrophysiology
• Imaging analysis
• Immunology assays
• Magnetic resonance imaging (MRI)
• Medicinal chemistry and custom synthesis
• Neurological/ neurodegenerative disorders
• Functional genomics and proteomics
• Radiation biology and models
• Sleep, circadian rhythm
• Toxin models
• Viral models

SRI offers comprehensive services in drug metabolism and pharmacokinetics, safety toxicology, safety pharmacology, and developmental and reproductive toxicology. Our expertise spans a wide range of pharmaceutical and therapeutic agents and we also offer testing of genetically engineered products and medical devices, such as combination 5d10(k) products, using protocols designed to meet your needs.

Our services include—but are not limited to—

• Bioanalytical chemistry
• Clinical laboratory services
• Development and reproductive toxicology
• Genetic toxicity
• Immunology services
• Molecular biology
• Pharmacokinetic/drug metabolism
• Toxicology and safety

SRI’s pre-formulation and formulation services help optimize safety and efficacy in drug development. Offerings range from preparation of dose formulations for nonclinical in vitro and in vivo safety studies, to cGMP manufacture and stability testing of finished drug product dosage forms for clinical trials.

• Our services include—but are not limited to—
  • Analytical chemistry
  • Clinical Manufacturing
  • Formulation development

SRI Clinical Analysis Laboratory (CAL) has a history of outstanding proficiency testing by the College of American Pathologists (CAP) and is staffed with highly qualified licensed clinical laboratory scientists with decades of experience in clinical laboratory testing and compliance.